Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

E. Palmerini, R. L. Jones, E. Marchesi, A. Paioli, M. Cesari, A. Longhi, C. Meazza, L. Coccoli, F. Fagioli, S. Asaftei, G. Grignani, A. Tamburini, S. M. Pollack, P. Picci, S. Ferrari

ABSTRACT

BACKGROUND: Few new compounds are available for relapsed osteosarcoma. We retrospectively evaluated the activity of gemcitabine (G) plus docetaxel (D) in patients with relapsed high-grade osteosarcoma and high-grade spindle cell sarcoma of bone (HGS). METHODS: Patients receiving G 900 mg/m(2) d 1, 8; D 75 mg/m(2) d 8, every 21 days were eligible. Primary end-point: progression-free survival (PFS) at 4 months; secondary end-point: overall survival (OS) and response rate. RESULTS: Fifty-one patients were included, with a median age of 17 years (8-71), 26 (51%) were pediatric patients. GD line of treatment: 2nd in 14 patients, ≥3rd in 37. 25 (49%) patients had metastases limited to lungs, 26 (51%) multiple sites. HISTOLOGY: 40 (78%) osteosarcoma, 11 (22%) HGS. Eight (16%) patients achieved surgical complete response (sCR2) after GD. Four-month PFS rate was 46%, and significantly better for patients with ECOG 0 (ECOG 0: 54% vs ECOG 1: 43% vs ECOG 2: 0%; p = 0.003), for patients undergoing metastasectomy after GD (sCR2 75% vs no-sCR2 40 %, p = 0.02) and for osteosarcoma (osteosarcoma 56% vs HGS 18%; p = 0.05), with no differences according to age, line of treatment, and pattern of metastases. Forty-six cases had RECIST measurable disease: 6 (13%) patients had a partial response (PR), 20 (43%) had stable disease (SD) and 20 (43%) had progressive disease (PD). The 1-year OS was 30%: 67% for PR, 54% for SD and 20% for PD (p = 0.005). CONCLUSIONS: GD is an active treatment for relapsed high-grade osteosarcoma, especially for ECOG 0 patients, and should be included in the therapeutic armamentarium of metastatic osteosarcoma. More... »

PAGES

280

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-016-2312-3

DOI

http://dx.doi.org/10.1186/s12885-016-2312-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046613263

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27098543


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Grading", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteosarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Taxoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Ortopedico Rizzoli", 
          "id": "https://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "PROMETEO Laboratory/Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy", 
            "PROMETEO Laboratory/Section of Chemotherapy, Research, Innovation & Technology (RIT) Department, Istituto Ortopedico Rizzoli, Via Pupilli, 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmerini", 
        "givenName": "E.", 
        "id": "sg:person.01210215667.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fred Hutchinson Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.270240.3", 
          "name": [
            "University of Washington/ Fred Hutchinson Cancer Research Center, Seattle, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jones", 
        "givenName": "R. L.", 
        "id": "sg:person.01110361365.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110361365.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Ortopedico Rizzoli", 
          "id": "https://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "PROMETEO Laboratory/Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marchesi", 
        "givenName": "E.", 
        "id": "sg:person.0720354404.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720354404.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Ortopedico Rizzoli", 
          "id": "https://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "PROMETEO Laboratory/Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paioli", 
        "givenName": "A.", 
        "id": "sg:person.01235471460.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235471460.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Ortopedico Rizzoli", 
          "id": "https://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "PROMETEO Laboratory/Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cesari", 
        "givenName": "M.", 
        "id": "sg:person.0711754347.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711754347.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Ortopedico Rizzoli", 
          "id": "https://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "PROMETEO Laboratory/Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Longhi", 
        "givenName": "A.", 
        "id": "sg:person.01167151157.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167151157.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Oncoematologia Pediatrica INT, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meazza", 
        "givenName": "C.", 
        "id": "sg:person.0667021302.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667021302.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "UO Oncoematologia Pediatrica Pisa, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coccoli", 
        "givenName": "L.", 
        "id": "sg:person.01003463365.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003463365.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oncoematologia Pediatrica Torino, Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fagioli", 
        "givenName": "F.", 
        "id": "sg:person.01202512663.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202512663.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oncoematologia Pediatrica Torino, Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asaftei", 
        "givenName": "S.", 
        "id": "sg:person.0744300243.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744300243.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "IRCCS Candiolo, Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grignani", 
        "givenName": "G.", 
        "id": "sg:person.0677322613.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677322613.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oncoematologia Azienda Ospedaliera Universitaria Meyer Pediatrica, Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamburini", 
        "givenName": "A.", 
        "id": "sg:person.0760232672.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760232672.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fred Hutchinson Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.270240.3", 
          "name": [
            "University of Washington/ Fred Hutchinson Cancer Research Center, Seattle, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pollack", 
        "givenName": "S. M.", 
        "id": "sg:person.01317174453.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317174453.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Ortopedico Rizzoli", 
          "id": "https://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Laboratory Research, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Picci", 
        "givenName": "P.", 
        "id": "sg:person.0753274552.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Ortopedico Rizzoli", 
          "id": "https://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "PROMETEO Laboratory/Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrari", 
        "givenName": "S.", 
        "id": "sg:person.013005321532.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/pbc.25035", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000439867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71186-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001675661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00043426-200205000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001916024"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00043426-200205000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001916024"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2011.12.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005233070"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.24368", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012038141"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.24368", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012038141"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2011-0467", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013325401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.20228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013508880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hys030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015030808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2010-0265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018821214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyr195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023842670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdu256", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029165450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71136-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032016934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cco.0b013e328122d73f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032302097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cco.0b013e328122d73f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032302097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23586", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032798754"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdr151", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033303847"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mpo.2950240205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037608512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/s1357714x00000025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040259501"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000328795", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041408809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(01)00398-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041730636"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.10.4117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044406195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19940515)73:10<2506::aid-cncr2820731009>3.0.co;2-s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050205166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e3182331ee8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051793411"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e3182331ee8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051793411"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mds314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052329164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.3.776", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.11.050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.03.141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.6.2378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083106813"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Few new compounds are available for relapsed osteosarcoma. We retrospectively evaluated the activity of gemcitabine (G) plus docetaxel (D) in patients with relapsed high-grade osteosarcoma and high-grade spindle cell sarcoma of bone (HGS).\nMETHODS: Patients receiving G 900 mg/m(2) d 1, 8; D 75 mg/m(2) d 8, every 21 days were eligible. Primary end-point: progression-free survival (PFS) at 4 months; secondary end-point: overall survival (OS) and response rate.\nRESULTS: Fifty-one patients were included, with a median age of 17 years (8-71), 26 (51%) were pediatric patients. GD line of treatment: 2nd in 14 patients, \u22653rd in 37. 25 (49%) patients had metastases limited to lungs, 26 (51%) multiple sites.\nHISTOLOGY: 40 (78%) osteosarcoma, 11 (22%) HGS. Eight (16%) patients achieved surgical complete response (sCR2) after GD. Four-month PFS rate was 46%, and significantly better for patients with ECOG 0 (ECOG 0: 54% vs ECOG 1: 43% vs ECOG 2: 0%; p = 0.003), for patients undergoing metastasectomy after GD (sCR2 75% vs no-sCR2 40 %, p = 0.02) and for osteosarcoma (osteosarcoma 56% vs HGS 18%; p = 0.05), with no differences according to age, line of treatment, and pattern of metastases. Forty-six cases had RECIST measurable disease: 6 (13%) patients had a partial response (PR), 20 (43%) had stable disease (SD) and 20 (43%) had progressive disease (PD). The 1-year OS was 30%: 67% for PR, 54% for SD and 20% for PD (p = 0.005).\nCONCLUSIONS: GD is an active treatment for relapsed high-grade osteosarcoma, especially for ECOG 0 patients, and should be included in the therapeutic armamentarium of metastatic osteosarcoma.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-016-2312-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone", 
    "pagination": "280", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "de0c48c1b625f693e903327ce25d2010d9f7660180a9c45be6834a29b819c5c0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27098543"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-016-2312-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046613263"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-016-2312-3", 
      "https://app.dimensions.ai/details/publication/pub.1046613263"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000515.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12885-016-2312-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2312-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2312-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2312-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2312-3'


 

This table displays all metadata directly associated to this object as RDF triples.

337 TRIPLES      21 PREDICATES      74 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-016-2312-3 schema:about N124c798d82ea4836bf0e8b1cdc13cec3
2 N3a56543c32d64eaaa8c27b3a1f712767
3 N3f9441baaabf4ce8b261edd9fe41da06
4 N62fde6a3e82448a9bcf77d66f172912f
5 N78381be333c648b2b08c9623f50087bd
6 N7c3ff21d37504407971515352351bc7b
7 N80d2a351f53e4941aafe15ba5c66d729
8 N92f6640fdc3840759ffff4541446c848
9 N934f8679bc8b47a3a2673a831a71866d
10 Nab74d108292c40b1a3c2db78b8764db5
11 Nbf387be0870f41a4b7c193fb4e1695a7
12 Nd13fffbd99ed4a6b96572443b1bd3e27
13 Nd8bc60f077ff41b0aaad5062cb19abc0
14 Ndaa31788e47a488fbee711f0bbd5b164
15 Ne8698f3085e64a6cb44035679e1fa173
16 Ne930a6d562494b40be1b9394b71af192
17 Nf1d74e87cd1d4771b8f553d98ef767de
18 Nf77f75fd2f3f4ebba601a1a98ab7c5e6
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author Nbf022135b56641238f279a9538d05bd1
22 schema:citation https://doi.org/10.1002/1097-0142(19940515)73:10<2506::aid-cncr2820731009>3.0.co;2-s
23 https://doi.org/10.1002/cncr.23586
24 https://doi.org/10.1002/cncr.24368
25 https://doi.org/10.1002/mpo.2950240205
26 https://doi.org/10.1002/pbc.20228
27 https://doi.org/10.1002/pbc.25035
28 https://doi.org/10.1016/j.ejca.2011.12.015
29 https://doi.org/10.1016/s0959-8049(01)00398-7
30 https://doi.org/10.1016/s1470-2045(14)71136-2
31 https://doi.org/10.1016/s1470-2045(14)71186-6
32 https://doi.org/10.1093/annonc/mdr151
33 https://doi.org/10.1093/annonc/mds314
34 https://doi.org/10.1093/annonc/mdu256
35 https://doi.org/10.1093/jjco/hyr195
36 https://doi.org/10.1093/jjco/hys030
37 https://doi.org/10.1097/00043426-200205000-00006
38 https://doi.org/10.1097/cco.0b013e328122d73f
39 https://doi.org/10.1097/mph.0b013e3182331ee8
40 https://doi.org/10.1155/s1357714x00000025
41 https://doi.org/10.1159/000328795
42 https://doi.org/10.1200/jco.1997.15.6.2378
43 https://doi.org/10.1200/jco.20.3.776
44 https://doi.org/10.1200/jco.2002.11.050
45 https://doi.org/10.1200/jco.2003.03.141
46 https://doi.org/10.1200/jco.2006.10.4117
47 https://doi.org/10.1634/theoncologist.2010-0265
48 https://doi.org/10.1634/theoncologist.2011-0467
49 schema:datePublished 2016-12
50 schema:datePublishedReg 2016-12-01
51 schema:description BACKGROUND: Few new compounds are available for relapsed osteosarcoma. We retrospectively evaluated the activity of gemcitabine (G) plus docetaxel (D) in patients with relapsed high-grade osteosarcoma and high-grade spindle cell sarcoma of bone (HGS). METHODS: Patients receiving G 900 mg/m(2) d 1, 8; D 75 mg/m(2) d 8, every 21 days were eligible. Primary end-point: progression-free survival (PFS) at 4 months; secondary end-point: overall survival (OS) and response rate. RESULTS: Fifty-one patients were included, with a median age of 17 years (8-71), 26 (51%) were pediatric patients. GD line of treatment: 2nd in 14 patients, ≥3rd in 37. 25 (49%) patients had metastases limited to lungs, 26 (51%) multiple sites. HISTOLOGY: 40 (78%) osteosarcoma, 11 (22%) HGS. Eight (16%) patients achieved surgical complete response (sCR2) after GD. Four-month PFS rate was 46%, and significantly better for patients with ECOG 0 (ECOG 0: 54% vs ECOG 1: 43% vs ECOG 2: 0%; p = 0.003), for patients undergoing metastasectomy after GD (sCR2 75% vs no-sCR2 40 %, p = 0.02) and for osteosarcoma (osteosarcoma 56% vs HGS 18%; p = 0.05), with no differences according to age, line of treatment, and pattern of metastases. Forty-six cases had RECIST measurable disease: 6 (13%) patients had a partial response (PR), 20 (43%) had stable disease (SD) and 20 (43%) had progressive disease (PD). The 1-year OS was 30%: 67% for PR, 54% for SD and 20% for PD (p = 0.005). CONCLUSIONS: GD is an active treatment for relapsed high-grade osteosarcoma, especially for ECOG 0 patients, and should be included in the therapeutic armamentarium of metastatic osteosarcoma.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree true
55 schema:isPartOf Na303cdf945564f898d7f05d4ea6a7754
56 Ndf6af3dec4034cffa993260f6882b3aa
57 sg:journal.1024632
58 schema:name Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
59 schema:pagination 280
60 schema:productId N2db0af2ffb5e4ac4bb54e3212d652f9b
61 N562e58fd78024e6589672004189b3d29
62 N86868c6aaef74247869b1ede1afaba74
63 N905ad79c506e430383e7299b5a497589
64 Nf1fae3881c6e45c894743a8f9fe3a14c
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046613263
66 https://doi.org/10.1186/s12885-016-2312-3
67 schema:sdDatePublished 2019-04-10T15:52
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher Nd41a8b5e4d0148e4b15e5edfebad114c
70 schema:url http://link.springer.com/10.1186%2Fs12885-016-2312-3
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N01e3dd7f33a64958a1d13a10cc70c75d rdf:first sg:person.0677322613.01
75 rdf:rest Nc03e109e9a25467e87e8fee91f371a34
76 N07a07c15e3b44acf953c57e0ab2bd626 rdf:first sg:person.0753274552.44
77 rdf:rest Nd96d0db348274596895ffce6f37b6a83
78 N124c798d82ea4836bf0e8b1cdc13cec3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Treatment Outcome
80 rdf:type schema:DefinedTerm
81 N1d5bdb24b03a433196ebbc150cf75421 rdf:first sg:person.01317174453.94
82 rdf:rest N07a07c15e3b44acf953c57e0ab2bd626
83 N2063141eda534fa5bf9ebc1d157254f8 rdf:first sg:person.01235471460.73
84 rdf:rest Nb6e981592ad447a8aaf0cb7f7bd2474a
85 N2db0af2ffb5e4ac4bb54e3212d652f9b schema:name nlm_unique_id
86 schema:value 100967800
87 rdf:type schema:PropertyValue
88 N318328cf95df406e927df932421c6a37 schema:name Oncoematologia Pediatrica Torino, Torino, Italy
89 rdf:type schema:Organization
90 N3a56543c32d64eaaa8c27b3a1f712767 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Kaplan-Meier Estimate
92 rdf:type schema:DefinedTerm
93 N3f9441baaabf4ce8b261edd9fe41da06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Recurrence
95 rdf:type schema:DefinedTerm
96 N562e58fd78024e6589672004189b3d29 schema:name dimensions_id
97 schema:value pub.1046613263
98 rdf:type schema:PropertyValue
99 N62fde6a3e82448a9bcf77d66f172912f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Neoplasm Recurrence, Local
101 rdf:type schema:DefinedTerm
102 N72c89e4a830f4ceb84d34c6ba261e87f schema:name UO Oncoematologia Pediatrica Pisa, Pisa, Italy
103 rdf:type schema:Organization
104 N78381be333c648b2b08c9623f50087bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Adolescent
106 rdf:type schema:DefinedTerm
107 N79ff326bda144d2c94f1681395b936b9 schema:name Oncoematologia Azienda Ospedaliera Universitaria Meyer Pediatrica, Firenze, Italy
108 rdf:type schema:Organization
109 N7af0140c577a400193413827ea5ff430 rdf:first sg:person.0720354404.13
110 rdf:rest N2063141eda534fa5bf9ebc1d157254f8
111 N7b2fb5ebc3684061b38c5f3524f06b37 rdf:first sg:person.01003463365.15
112 rdf:rest Ncbfa020db17a4a4e888c2019a1808ee1
113 N7c3ff21d37504407971515352351bc7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Sarcoma
115 rdf:type schema:DefinedTerm
116 N7d1efee89d9a4963b6b9fb63b09d477f rdf:first sg:person.0744300243.09
117 rdf:rest N01e3dd7f33a64958a1d13a10cc70c75d
118 N80d2a351f53e4941aafe15ba5c66d729 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Neoplasm Grading
120 rdf:type schema:DefinedTerm
121 N86868c6aaef74247869b1ede1afaba74 schema:name readcube_id
122 schema:value de0c48c1b625f693e903327ce25d2010d9f7660180a9c45be6834a29b819c5c0
123 rdf:type schema:PropertyValue
124 N905ad79c506e430383e7299b5a497589 schema:name pubmed_id
125 schema:value 27098543
126 rdf:type schema:PropertyValue
127 N92f6640fdc3840759ffff4541446c848 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Male
129 rdf:type schema:DefinedTerm
130 N934f8679bc8b47a3a2673a831a71866d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Aged
132 rdf:type schema:DefinedTerm
133 Na303cdf945564f898d7f05d4ea6a7754 schema:issueNumber 1
134 rdf:type schema:PublicationIssue
135 Na32cfcddde69458db65e797ff1049b6c rdf:first sg:person.01167151157.23
136 rdf:rest Ncfdebd3b552841e88ac495409627c232
137 Nab74d108292c40b1a3c2db78b8764db5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Taxoids
139 rdf:type schema:DefinedTerm
140 Nb6e981592ad447a8aaf0cb7f7bd2474a rdf:first sg:person.0711754347.80
141 rdf:rest Na32cfcddde69458db65e797ff1049b6c
142 Nb9cada45f4904c6ea7d05ff8e2af27b2 schema:name Oncoematologia Pediatrica Torino, Torino, Italy
143 rdf:type schema:Organization
144 Nbb65dba991b84ce086ce688af3917bcb schema:name IRCCS Candiolo, Torino, Italy
145 rdf:type schema:Organization
146 Nbf022135b56641238f279a9538d05bd1 rdf:first sg:person.01210215667.35
147 rdf:rest Ncc5853e400aa4422803b2ddbc1a47310
148 Nbf387be0870f41a4b7c193fb4e1695a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Disease-Free Survival
150 rdf:type schema:DefinedTerm
151 Nc03e109e9a25467e87e8fee91f371a34 rdf:first sg:person.0760232672.04
152 rdf:rest N1d5bdb24b03a433196ebbc150cf75421
153 Ncbfa020db17a4a4e888c2019a1808ee1 rdf:first sg:person.01202512663.01
154 rdf:rest N7d1efee89d9a4963b6b9fb63b09d477f
155 Ncc5853e400aa4422803b2ddbc1a47310 rdf:first sg:person.01110361365.31
156 rdf:rest N7af0140c577a400193413827ea5ff430
157 Ncfdebd3b552841e88ac495409627c232 rdf:first sg:person.0667021302.33
158 rdf:rest N7b2fb5ebc3684061b38c5f3524f06b37
159 Nd13fffbd99ed4a6b96572443b1bd3e27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Child
161 rdf:type schema:DefinedTerm
162 Nd41a8b5e4d0148e4b15e5edfebad114c schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 Nd8bc60f077ff41b0aaad5062cb19abc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Deoxycytidine
166 rdf:type schema:DefinedTerm
167 Nd96d0db348274596895ffce6f37b6a83 rdf:first sg:person.013005321532.44
168 rdf:rest rdf:nil
169 Ndaa31788e47a488fbee711f0bbd5b164 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Female
171 rdf:type schema:DefinedTerm
172 Ndf6af3dec4034cffa993260f6882b3aa schema:volumeNumber 16
173 rdf:type schema:PublicationVolume
174 Ne8698f3085e64a6cb44035679e1fa173 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Osteosarcoma
176 rdf:type schema:DefinedTerm
177 Ne930a6d562494b40be1b9394b71af192 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Middle Aged
179 rdf:type schema:DefinedTerm
180 Nf1d74e87cd1d4771b8f553d98ef767de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Humans
182 rdf:type schema:DefinedTerm
183 Nf1fae3881c6e45c894743a8f9fe3a14c schema:name doi
184 schema:value 10.1186/s12885-016-2312-3
185 rdf:type schema:PropertyValue
186 Nf77f75fd2f3f4ebba601a1a98ab7c5e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Adult
188 rdf:type schema:DefinedTerm
189 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
190 schema:name Medical and Health Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
193 schema:name Clinical Sciences
194 rdf:type schema:DefinedTerm
195 sg:journal.1024632 schema:issn 1471-2407
196 schema:name BMC Cancer
197 rdf:type schema:Periodical
198 sg:person.01003463365.15 schema:affiliation N72c89e4a830f4ceb84d34c6ba261e87f
199 schema:familyName Coccoli
200 schema:givenName L.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003463365.15
202 rdf:type schema:Person
203 sg:person.01110361365.31 schema:affiliation https://www.grid.ac/institutes/grid.270240.3
204 schema:familyName Jones
205 schema:givenName R. L.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110361365.31
207 rdf:type schema:Person
208 sg:person.01167151157.23 schema:affiliation https://www.grid.ac/institutes/grid.419038.7
209 schema:familyName Longhi
210 schema:givenName A.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167151157.23
212 rdf:type schema:Person
213 sg:person.01202512663.01 schema:affiliation N318328cf95df406e927df932421c6a37
214 schema:familyName Fagioli
215 schema:givenName F.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202512663.01
217 rdf:type schema:Person
218 sg:person.01210215667.35 schema:affiliation https://www.grid.ac/institutes/grid.419038.7
219 schema:familyName Palmerini
220 schema:givenName E.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35
222 rdf:type schema:Person
223 sg:person.01235471460.73 schema:affiliation https://www.grid.ac/institutes/grid.419038.7
224 schema:familyName Paioli
225 schema:givenName A.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235471460.73
227 rdf:type schema:Person
228 sg:person.013005321532.44 schema:affiliation https://www.grid.ac/institutes/grid.419038.7
229 schema:familyName Ferrari
230 schema:givenName S.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44
232 rdf:type schema:Person
233 sg:person.01317174453.94 schema:affiliation https://www.grid.ac/institutes/grid.270240.3
234 schema:familyName Pollack
235 schema:givenName S. M.
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317174453.94
237 rdf:type schema:Person
238 sg:person.0667021302.33 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
239 schema:familyName Meazza
240 schema:givenName C.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667021302.33
242 rdf:type schema:Person
243 sg:person.0677322613.01 schema:affiliation Nbb65dba991b84ce086ce688af3917bcb
244 schema:familyName Grignani
245 schema:givenName G.
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677322613.01
247 rdf:type schema:Person
248 sg:person.0711754347.80 schema:affiliation https://www.grid.ac/institutes/grid.419038.7
249 schema:familyName Cesari
250 schema:givenName M.
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711754347.80
252 rdf:type schema:Person
253 sg:person.0720354404.13 schema:affiliation https://www.grid.ac/institutes/grid.419038.7
254 schema:familyName Marchesi
255 schema:givenName E.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720354404.13
257 rdf:type schema:Person
258 sg:person.0744300243.09 schema:affiliation Nb9cada45f4904c6ea7d05ff8e2af27b2
259 schema:familyName Asaftei
260 schema:givenName S.
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744300243.09
262 rdf:type schema:Person
263 sg:person.0753274552.44 schema:affiliation https://www.grid.ac/institutes/grid.419038.7
264 schema:familyName Picci
265 schema:givenName P.
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44
267 rdf:type schema:Person
268 sg:person.0760232672.04 schema:affiliation N79ff326bda144d2c94f1681395b936b9
269 schema:familyName Tamburini
270 schema:givenName A.
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760232672.04
272 rdf:type schema:Person
273 https://doi.org/10.1002/1097-0142(19940515)73:10<2506::aid-cncr2820731009>3.0.co;2-s schema:sameAs https://app.dimensions.ai/details/publication/pub.1050205166
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1002/cncr.23586 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032798754
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1002/cncr.24368 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012038141
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1002/mpo.2950240205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037608512
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1002/pbc.20228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013508880
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1002/pbc.25035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000439867
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1016/j.ejca.2011.12.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005233070
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1016/s0959-8049(01)00398-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041730636
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1016/s1470-2045(14)71136-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032016934
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1016/s1470-2045(14)71186-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001675661
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1093/annonc/mdr151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033303847
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1093/annonc/mds314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052329164
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1093/annonc/mdu256 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029165450
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1093/jjco/hyr195 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023842670
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1093/jjco/hys030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015030808
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1097/00043426-200205000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001916024
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1097/cco.0b013e328122d73f schema:sameAs https://app.dimensions.ai/details/publication/pub.1032302097
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1097/mph.0b013e3182331ee8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051793411
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1155/s1357714x00000025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040259501
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1159/000328795 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041408809
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1200/jco.1997.15.6.2378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083106813
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1200/jco.20.3.776 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202797
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1200/jco.2002.11.050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203169
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1200/jco.2003.03.141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203479
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1200/jco.2006.10.4117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044406195
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1634/theoncologist.2010-0265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018821214
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1634/theoncologist.2011-0467 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013325401
326 rdf:type schema:CreativeWork
327 https://www.grid.ac/institutes/grid.270240.3 schema:alternateName Fred Hutchinson Cancer Research Center
328 schema:name University of Washington/ Fred Hutchinson Cancer Research Center, Seattle, USA
329 rdf:type schema:Organization
330 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
331 schema:name Oncoematologia Pediatrica INT, Milan, Italy
332 rdf:type schema:Organization
333 https://www.grid.ac/institutes/grid.419038.7 schema:alternateName Istituto Ortopedico Rizzoli
334 schema:name Laboratory Research, Istituto Ortopedico Rizzoli, Bologna, Italy
335 PROMETEO Laboratory/Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy
336 PROMETEO Laboratory/Section of Chemotherapy, Research, Innovation & Technology (RIT) Department, Istituto Ortopedico Rizzoli, Via Pupilli, 1, 40136, Bologna, Italy
337 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...